osudhkosh

Generic

Peritoneal Dialysis Solution (Calcium Chloride + Dextrose + Magnesium Chloride + Sodium Acetate + Sodium Chloride)

2 brands available in the market

At a glance

Peritoneal Dialysis Solution (Calcium Chloride + Dextrose + Magnesium Chloride + Sodium Acetate + Sodium Chloride) is a sterile solution used for peritoneal dialysis in patients with end-stage renal disease (ESRD). It helps remove waste products and excess fluid from the body.

Description

Peritoneal Dialysis Solution is a sterile, nonpyrogenic solution used for peritoneal dialysis in patients with end-stage renal disease (ESRD). The solution contains Calcium Chloride, Dextrose Anhydrous, Magnesium Chloride, Sodium Acetate, and Sodium Chloride.

Calcium Chloride prevents and treats negative calcium balance and regulates nerve and muscle function. Dextrose provides calories and water for hydration and reduces protein and nitrogen loss. Sodium Chloride is important for electrolyte and fluid balance and osmotic pressure control. Sodium Acetate is used for fluid and electrolyte replenishment with metabolic alkalinizing ability.

Indications
  • Peritoneal Dialysis - End Stage Renal Disease (ESRD)
Therapeutic class

Dialysis Solution

Pharmacological class

Peritoneal Dialysis Fluid

Pharmacology

Calcium Chloride prevents or treats negative calcium balance and regulates action potential excitation threshold to facilitate nerve and muscle function. Sodium Chloride is the major extracellular cation important for electrolyte and fluid balance, osmotic pressure control, and water distribution. Sodium Acetate is used for fluid and electrolyte replenishment with metabolic alkalinizing ability. Dextrose provides calories and water for hydration, reduces protein and nitrogen loss, and promotes glycogen deposition in the liver.

Mechanism of action

When the solution is instilled into the peritoneal cavity, waste products (urea, creatinine) and excess fluid are transferred from the blood to the peritoneal cavity through osmosis and diffusion, which are then drained out.

Dosage

Adults (Intermittent Peritoneal Dialysis - IPD): 2 litres of solution is instilled into the abdominal cavity over a period of 1 hour, then drained from the cavity. The exchange should be continued for 8-36 hours.

Note: Dose, infusion time, and exchange frequency are determined based on the patient's clinical condition and physician's advice.

Administration

For peritoneal dialysis use only. Administered by healthcare professionals during dialysis. Patient should not self-administer.

Missed dose

Hospital-only medicine. Administered by doctor or nurse during peritoneal dialysis. Missed dose concept does not apply (part of the dialysis procedure).

Side effects

Dialysis-related: Loss of amino acids and water-soluble vitamins may occur.

Fluid and electrolyte imbalance: Fluid and electrolyte imbalance, hypovolemia, hypotension, or muscle cramping may occur.

Other: Peritonitis, abdominal pain, infection (catheter infection), hyperglycemia (due to dextrose).

Precautions & warnings
  • For peritoneal dialysis use only.
  • Caution in patients with illness, infection, or history of abdominal surgery.
  • Regular monitoring of electrolytes, blood glucose, and other parameters is required during dialysis.
  • Caution/contraindicated in excessive obesity and pregnancy.
Contraindications
  • Excessive obesity
  • Pregnancy
Drug interactions
  • Antibiotics, heparin, insulin: Interactions may occur with peritoneal dialysis solution; follow physician's advice.
Food interactions

No food-related restrictions (peritoneal administration).

Use in pregnancy

Contraindicated during pregnancy.

Use in lactation

Adequate information on use during lactation is not available; consult your doctor.

Pediatric use

Use in children under medical supervision.

Geriatric use

Elderly patients require monitoring of dialysis parameters and electrolytes.

Renal / hepatic impairment
Renal impairment: Used for peritoneal dialysis in end-stage renal disease (ESRD).

Hepatic impairment: Caution required in liver disease; consult your doctor.
Overdose effects

Overdose symptoms: Fluid overload, electrolyte imbalance, hyperglycemia, hypernatremia, hypercalcemia. Consult your doctor immediately if overdose is suspected.

Storage conditions

Store below 30°C, away from light. Keep out of reach of children.

Chemical structure

Calcium Chloride + Dextrose Anhydrous + Magnesium Chloride + Sodium Acetate + Sodium Chloride

Common questions

What is this solution used for?
It is used for peritoneal dialysis in patients with end-stage renal disease (ESRD).
How is it administered?
2 litres of solution is instilled into the abdominal cavity over 1 hour, then drained. The exchange is continued for 8-36 hours.
What are the side effects?
Loss of amino acids and vitamins, fluid and electrolyte imbalance, hypovolemia, hypotension, muscle cramping, peritonitis may occur.
Who should not use this solution?
Patients with excessive obesity and pregnancy should not use it.
Can it be used during pregnancy?
Contraindicated during pregnancy.
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.